← Back to searchRecruitingRecruiting
Radiology Registry on Pancreatic Malignancies
NCT05714111 · IRCCS San Raffaele
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.
Eligibility criteria
Inclusion Criteria:
* ≥18 years of age
* Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
* able and willing to sign informed consent
Exclusion Criteria:
* Patients with non-primary pancreatic disease
Study design
Enrollment target: 1300 participants
Age groups: adult, older_adult
Timeline
Starts: 2022-03-04
Estimated completion: 2030-03-30
Last updated: 2024-04-12
Interventions
Other: Radiology evaluations and interventions
Primary outcomes
- • Progression- free survival (From date of intervention until the date of first documented progression, up to a maximum of 3 years)
- • Local progression free survival (From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years)
Sponsor
IRCCS San Raffaele · other
All locations (1)
Department of Radiology, IRCCS Ospedale San RaffaeleRecruiting
Milan, Italy